Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal disease. Regen Med. 2015..
Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease. Stem Cell Res. 2015;15(3):495-505..
Mesenchymal stem cells as novel microRNA delivery vehicles in kidney disease. Nephrology (Carlton). 2015..